Madarosis: a qualitative study to assess perceptions and experience of Australian patients with early breast cancer treated with taxane-based chemotherapy.
Kortnye SmithJ WinstanleyF BoyleA O'ReillyM WhiteY C AntillPublished in: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer (2017)
This study highlights the significant impact of madarosis on patients, providing the first published analysis of patient's attitude and perception of eyelash and eyebrow loss during chemotherapy. Further research in this area is required and will be benefitted from the development of a dedicated instrument/questionnaire that can capture and measure the impact of madarosis on QoL and allow development of clinical trial strategies.
Keyphrases
- clinical trial
- early breast cancer
- end stage renal disease
- newly diagnosed
- ejection fraction
- chronic kidney disease
- locally advanced
- patient reported outcomes
- case report
- prognostic factors
- squamous cell carcinoma
- systematic review
- cross sectional
- patient reported
- randomized controlled trial
- radiation therapy
- open label
- study protocol
- metastatic breast cancer